Kezar Life Sciences, Inc. (KZR)
$7.29+0.00%Close
BUYBULL · day 30
Key stats
- Market cap
- $54M
- Beta
- 0.41
- P/E (TTM)
- -1.18
- 1W
- -1.35%
- 1M
- -1.09%
- vs SPY 1W
- -1.78%
- vs SPY 1M
- -3.15%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on KZR?
- LOPJLB’s latest quantitative signal on Kezar Life Sciences, Inc. (KZR) is BUY in a BULL regime. Signals are updated daily.
- What market regime is KZR in?
- Kezar Life Sciences, Inc. (KZR) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Kezar Life Sciences, Inc. (KZR) do?
- Kezar Life Sciences, Inc. is a United States-based clinical-stage biopharmaceutical company focused on identifying and advancing novel small molecule therapies. Its mission is to address significant unmet medical needs in both immune-mediated diseases and various forms of cancer. The company's most advanced experimental drug is KZR-616, a specialized immunoproteasome inhibitor. This candidate i…